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Introduction
Despite vast advances about anticancer drugs during the last decade, cancer is still one of the important worries of the world [1, 2] . Ineffective accumulation of drugs in tumors, lack of tumor specificity, heterogeneity of cancer cells, drug toxicity and drug resistance are factors that causes the lack of efficiency in cancer therapy [1, 3, 4] . Epirubicin (EPR) is an anthracycline drug that has been used alone or in combination with other drugs for treatment of various cancers such as breast, ovarian, gastric and lung [5, 6] .
EPR is a stereoisomer of doxorubicin and is flavoured over it. It has been shown that EPR is generally more successful than doxorubicin due to the higher tumor therapeutic efficiency and less side effects [7, 8] . In fact, as a consequence of the reorientation of the hydroxyl group in the 4'-position of the daunosamine ring, epirubicin finds different pharmacologic properties than doxorubicin [9] . First, it has a lower pKa. Accordingly, it is more lipophilic and better able to penetrate cells. Second, the glucuronidation of epirubicin and epirubicinol to inactive metabolites leads to a shorter terminal half-life for epirubicin (30 hours) compared with doxorubicin (45 hours) [8, 9] . Third, higher doses of epirubicin are required to produce the same degree of toxicity as doxorubicin. The doxorubicin-epirubicin dose ratios for similar toxicities are 1:1.2 for hematologic, 1:1.5 for nonhematologic, and 1:1.8 for cardiac [8, 10] .
Although EPR exhibited activity in all phases of the cell cycle but it was active mostly in S and G2 phases. The antineoplastic effect of epirubicin occurs through a number of mechanisms. First, it intercalates between DNA nucleotide base pairs, resulting in the inhibition of DNA, RNA, and protein synthesis. Second, the intercalation leads to topoisomerase II cleavage of DNA, which results in cytocidal activity. Third, epirubicin inhibits DNA helicase activity, which ultimately interferes with replication and transcription [10, 11] . Various experiments have shown that EPR inhibits cell proliferation and DNA synthesis in various carcinoma cell lines. Although fewer, like chemotherapy drugs, EPR still shows side effects such as cardio toxicity and myelosuppression [7] . Development of resistance to a certain dose of anticancer drugs is another major limitation of EPR. EPR is a hydrophilic drug with high volume of distribution [11] .
Drug delivery systems modify the efficacy and toxicity of anticancer drugs. Moreover, drug delivery systems can avoid multi drug resistance (MDR) created through factors such as Pglycoprotein and multi drug resistance proteins (MRPs) [12, 13, 14, 15, 16, 17] . Chemical conjugation with a parent drug as "Prodrug" strategy is one of the drug delivery systems that has been widely used in EPR delivery [12] . Several methods have been used to improve EPR delivery, including using nanodiamond [18] , SLN (solid lipid nanoparticles) [19] , phospholipids as multi drug resistance modulators of the epirubicin transport [20] , carbon nanoparticles [21] , and PLGA nanoparticles [22] .
Peptides and proteins are generally worthy in many aspects, such as their possible high potency, good selectivity and acceptable toxicity [23] . Two decades ago, a new kind of peptides, commonly known as cell penetrating peptides (CPPs), was discovered. They have been extracted from natural proteins and have the capability to cross cellular membranes and mediate the uptake of a wide range of macromolecular cargoes [1, 24, 25, 26, 27] . The discovered peptides as non-invasive vectors with very limited toxicity introduced a novel field in drug delivery [28] . In addition, they can be modified or designed de novo. They are typically short; usually 5-30 amino acids long [27, 29, 30, 31, 32, 33, 34] . These bioactive and biodegradable peptides are able to carry and deliver their cargoes such as nucleic acids, proteins, drugs, or imaging agents, to the cytoplasm or nuclei of cells [29, 32, 33, 34] . In the recent years, numerous natural and synthetic CPPs such as polyarginines, TAT (trans-acting activator of transcription) [26] and peptide amphiphiles (PA) [22] have improved the cellular uptake of various drugs such as Taxol [35] , methotrexate [16] , and doxorubicin [12] . Among these CPPs, peptide amphiphiles appear to be among efficient systems in drug delivery [36, 37, 38] . Universally, peptide amphiphiles consist of hydrophobic segments such as tryptophan and charged segments such as arginine or lysine [36] . These peptides have a helical secondary structure with the hydrophobic and hydrophilic domains. They use the charged region for cell membrane interaction and the hydrophobic region for membrane perturbation and translocation [29, 39] . Moreover, several studies have shown that the presence of tryptophan and backbone spacing can affect the uptake efficiency as well as its mechanism [40] .
In the present study several novel CPPs based on different designs containing lysine and tryptophan were synthesized. Highly active EPR (instead of Doxorubicin) was utilized as a drug. These peptides were then conjugated to EPR to improve the antitumor activity of the drug in MCF-7 breast cell line. Their corresponding nano-assemblies were prepared by noncovalent binding of the peptides and polyglutamate, with two different chain lengths. Finally, cytotoxicity, intracellular uptake and antitumor activity of the synthesized peptides as well as their nanoparticles were investigated and compared.
Materials and Methods

Materials
Classical glass reaction vessels suitable for performing solid-phase peptide synthesis (SPPS) were made by glassblowers. All of the amino acids (lysine, tryptophan and glutamate) and Rink amid-resin were purchased from Aapptec [15] . N, N, N′, N′-Tetramethyl-O- Sigma-Aldrich [15] . Potassium cyanide (KCN), ninhydrin and pyridine were from Merck (Germany). MCF-7 cells were purchased from Pasteur Institute (Iran).
Synthesis of peptides
Six linear peptides named (KW)4, (KW)5, K3W4K2, K3W4K3, W2K4W2 and W3K4W3
were synthesized using the hydrophobic (tryptophan, W) and charged (lysine, K) amino acids with various designs as presented in Table 1 . Overall methods were carried out according to the previously reported procedure [36, 41, 42] . Briefly, all peptides were synthesized manually by solid-phase peptide synthesis method, assembled on Rink-Amide AM resin by mixture volume of 10 ml per 100 mg peptide) was added to the resin. After shaking the mixture at room temperature for 2 h, the resin was collected and washed with another 2 ml fresh cleavage cocktail. The medium of the combined filtrates were evaporated and reduced into a minimum volume using dry nitrogen. The crude unreacted peptide was precipitated by adding excess volume (ten-fold) of cold diethyl ether and centrifugation at 4000 rpm for 5 min. Finally, the product was further washed with diethyl ether (50 ml) twice and then lyophilized. The schematic peptide synthesis of K3W4K3 is illustrated in Figure 1a .
Fluorescent labeling of the peptides on the resin
Fmoc protecting group was removed from N-terminal of all synthesized peptides using piperidine solution in DMF (20%, 2 ml, 30 min). A solution of 1/1 equivalent of FITC was provided in pyridine/DMF/DCM (12:7:5). Then FITC was attached to the peptides through adding the above solution to the resin-peptides (0.049 mmol) followed by an overnight mixing. The FITC-labeled peptides were evaluated by Kaiser Test to confirm the success of labeling process [42] . The schematic synthesis of FITC-labeled K3W4K3 is demonstrated in Figure 1b .
Preparation of nanoparticles
Peptide nanoparticles were synthesized by conjugation of the linear peptides to polyglutamate (E), with two chain lengths of E4 (EEEE) and E8 (EEEEEEEE). The synthesized linear peptides dissolved in DMSO were added to the polyglutamate E4 and E8 solution in DMSO, at different proportions of 1:1, 1:5 and 1:10 (v/v). Then, the prepared peptide solutions were sonicated so that the nanoparticles were formed through self-assembly by electrostatic attraction.
Determination of particle size
Morphology and size of the synthesized CPPs and nanoparticles were investigated by scanning electron microscopy (SEM). Each sample was dissolved in DMSO and distilled water (1:99 v/v), dropped onto an aluminum plate and lyophilized. The prepared slides were then visualized using a Philips XL electron microscope.
Preparation of peptide-drug conjugates
Conjugates of peptide-drug (CPP-EPR for various CPPs) were synthesized through reaction of amine group in peptide and hydroxyl group in EPR drug using a succinyl spacer. When succinic anhydride binds to the peptides as a linker, NH2 group of the peptide is changed to a carboxyl moiety. N-terminal of the prepared peptides was deprotected using piperidine in DMF (20%). Then the deprotected peptides were treated with succinic anhydride (1.5 eq) and DIEPA (3 eq) in DMF for 2 h. Figure 1c .
Drug loading measurement
UV spectra were obtained in order to evaluate the conjugation of EPR to various CPPs using a UV spectrophotometer. Afterward, absorbance of the unreacted EPR for each sample and the standard solution (first EPR concentration) were measured at the wavelength of 504 nm.
Loading of EPR (%) was calculated from Equation (1).
Equation (1) Where Af and As represent the optical absorbance of the sample and the standard, respectively.
Cell culture
Cellular studies were performed using MCF-7 (human breast adenocarcinoma) cell line. The cells were cultured on cell culture flasks in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS; Gibco, USA) and 1% antibiotic-antimycotic (Penicillin-Streptomycin;
Gibco, USA) in an incubator (5% CO2 ) at 37 °C.
Cytotoxicity and anti-proliferative assay
The All of the results were blank corrected. The experiment was run for 6 replicates. Antiproliferative activity was calculated according to Equation (2).
Equation (2) Where AS570 and AS650 correspond to the absorbance of treated samples at the respective λ = 570 and 650 nm; AC570 and AC650 are the corresponding absorbance of untreated control cells.
Fluorescence microscopy
The cellular uptake of CPPs and the corresponding nanoparticles were visualized using fluorescence microscopy. MCF-7 cells were seeded on the coverslips placed inside the six well plates at a density of 1 × 10 5 cells per well and incubated at 37 ºC and 5% CO2 for 24 h.
Then, the cells were treated with the FITC-CPPs and FITC-CPPs-E8 nanoparticles in serumfree culture medium each at the concentration of 10, 25 and 50 μM and incubated for 2 h.
Subsequently, the medium of each well was aspirated and the cells were washed three times with cold phosphate buffered saline (PBS). For fixing the cells, 200 µl of 2% formaldehyde solution in PBS was added to each well and incubated at 37 °C for 15 min followed by washing three times with PBS. Then, the samples were visualized by a fluorescence microscope (Olympus IX81, Olympus Optical Co. Ltd., Japan).
Cell uptake quantification by flow cytometry
For cellular uptake quantification, flow cytometry assay was performed. MCF-7 cells were seeded in 6-well plates at a density of 2 × 10 5 cells/well and incubated at 37 ºC and 5% CO2 
Statistical analysis
The data were expressed as mean ± standard deviation of 3 to 6 determinations. Statistical analysis was performed using Graphpad Prism Software Inc. version 5.04 (Inc. La Jolla, CA, USA). Different samples were compared using two-way analysis of variance (ANOVA). The differences were quoted statistically significant where P < 0.05. The significance level for pair wise comparisons was adjusted by Bonferroni method using Student t-test.
Results
Different linear peptides were synthesized on the Rink amide resin. Peptide synthesis was confirmed using Kaiser Test. In the next step, FITC was coupled to the synthesized peptides to investigate their uptake efficiency. FITC labeling was also confirmed by Kaiser Test.
CPPs-Drug conjugates (CPPs-EPR) were then prepared using a succinic linker. CPPs, FITCCPPs and CPPs-EPR were cleaved from the resin using the cleavage cocktail. EPR conjugation to CPPs and EPR loading were evaluated by UV spectrophotometry. Afterward, peptide nanoparticles were synthesized by conjugation of the peptides to poly glutamate (E), with two chain lengths, E4 and E8. Different synthesized CPPs and the corresponding nanoparticles were finally characterized by scanning electron microscopy (supplementary data, Figure S1 ), cytotoxicity, cellular uptake and anti-proliferative activity
Cytotoxicity
As an efficient delivery vector of anti-cancer drugs, blank CPPs and nanoparticles must have W3K4W3 showed the lowest cytotoxicity (16%, 21% and 22%, respectively) at the concentration of 10 µM (P<0.001). In addition, at the highest concentration (25 µM), cytotoxicity of W3K4W3 was the lowest (22%) followed by (KW)5 and K3W4K3 peptides (32% and 35%, P < 0.00001). Incubation time also affected the cytotoxicity of the peptides.
Increasing the incubation time from 24 (supplementary data, Figure S2 ) to 48 h (Figure 2) resulted in higher cytotoxicities (P < 0.0001). As illustrated in Figure 2a , (KW)5 showed the lowest cytotoxicity at concentration of 5 µM (15%, P < 0.01). The lowest cytotoxicity was observed for K2W4K2 and K3W4K3 (25% and 26%, p < 0.001) when the concentration was 10 µM. In the cases of (KW)5 and K3W4K3 (42% and 42%, P < 0.01) the lowest toxicity was obtained at 25 µM. Binding of E4 to peptides led to a significant reduction in the cytotoxicity at different concentrations for both 24 (P<0.0001) and 48 h (P<0.001) incubation times ( Figure 2b ). As demonstrated in Figure 2c , binding of E8 to peptides also resulted in a significant decrease in the cytotoxicity at different concentrations for all nanoparticles at the both incubation times, 24 and 48 h (P < 0.00001 and P < 0.0001). Interestingly, CPPs-E8 nanoparticles showed lower cytotoxicity than CPPs-E4 nanoparticles (P < 0.001). Therefore, CPPs-E8 nanoparticles possessed the lowest cytotoxicity among all nanoparticles. All of CPPs-E8 nanoparticles showed very low cytotoxicity (<20%) even at the highest concentration (25 µM) except (KW)4-E8 (at 10 and 25 µM) and K2W4K2-E8 (just at 25 µM).
Cellular uptake by fluorescence microscopy
Thecellular uptake (intracellular localization) was first visualized by fluorescent microscopy. It was demonstrated that W2K4W2 (both peptide and its nanoparticles) had the lowest cellular uptake.
Cellular uptake by flow cytometry
Flow cytometry was performed in order to evaluate and compare the cellular uptake ability of different peptides and their nanoparticles (FITC-CPPs and FITC-CPPs-E8 nanoparticles).
Just like fluorescence microscopy, MCF-7 cells were incubated with different concentrations of the samples for 2 h at 37 ºC. As shown in Figure 4 , the uptake was concentration Although, the cell uptake of W2K4W2-E8 (Figure 4d ) was significantly higher than its corresponding CPP (W2K4W2) at the concentrations of 25 μM (P < 0.0001) and 50 μM (p < 0.0001), it still exhibited the lowest percentage of cellular uptake compared to all other CPPs-E8 nanoparticles (P<0.00001). Flow cytometry histograms of K3W4K3 and K3W4K3-E8
each at various concentrations of 10, 25 and 50 µM are presented in Figure 5 .
Drug loading measurement
Following the conjugation of EPR to different CPPs, conjugation was confirmed using UV spectrophotometry (supplementary data, Figure S4 ).
Antitumor activity of drug loaded CPPs
To determine whether the synthesized peptides and nanoparticles can be utilized for delivery of biologically relevant doses of EPR to cells, EPR was conjugated to them and the antitumor (anti-proliferative) activity of EPR was then examined and compared in MCF-7 cells at various concentrations. As illustrated in Figure S5a 
K3W4K3-E8-EPR nanoparticles exhibited the highest anti-proliferative activity (92%) for all
CPPs-E8-EPR at 25 µM following incubation for 48 h (P < 0.05).
Discussion
Coupling of EPR to CPPs has been employed as one of the specific methods to deliver drug molecules into various cell lines. In the present study, different peptide sequence designs were chosen for peptide synthesis to examine how the presence of tryptophan and its position along with lysine and then peptide conjugation with 2 different chain lengths of poly glutamate may influence the cellular uptake and cytotoxicity of the drug.
The cytotoxicity of the synthesized CPPs and the corresponding nanoparticles (-E4 and -E8)
was investigated as a function of concentrations at two incubation times of 24 (supplementary data, Figure S2 ) and 48 h ( concentration, peptide sequence (structure, length and charge), and lipid composition [43] .
K2W4K2 might be translocated by a different internalization mechanism from the other peptides. The probable mechanism for this peptide might be the caveolin pathway [44] . It was reported that accumulation of the caveolins in the endoplasmic reticulum leads to an apparent concentration of the proteins in lipid droplets [45] . Hence, it is possible that K2W4K2 may be associated with lipid droplets or other cytoplasmic particles and this peptide might need longer time to enter to the nucleus [44] . Both peptide and-E8 nanoparticle of W2K4W2 displayed the lowest fluorescence inside the cells which is possibly due to its low cellular uptake, which means its weak internalization into the cells. Although, the cell uptake of W2K4W2-E8 (Figure 4d ) was significantly higher than its corresponding CPP (W2K4W2) at the concentrations of 25 μM and 50 μM, it still exhibited the lowest percentage of cellular uptake compared to all other CPPs-E8 nanoparticles which is in agreement with the result of fluorescence microscopy. It was reported that the addition of tryptophan amino acid could improve cellular uptake efficiency and peptides with sequences containing tryptophans in the middle or along the peptide sequence resulted in high uptake [40] . Interestingly, it was obtained that the cytotoxicity decreased markedly and the cellular uptake increased partly following the coupling of E8 and E4 to CPPs and synthesizing the nanoparticles. CPPs -E8 showed less cytotoxicity and more improved delivery of EPR compared to CPPs -E4. CPPs present a great diversity in terms of amino acid composition and 3D structure, with examples of cationic, anionic, and neutral sequences showing varying degrees of hydrophobicity and polarity. The various CPPs sequences may lead to different modes of cellular uptake, and different levels of uptake. CPPs can traverse membranes in order to enter cells via different uptake mechanisms. Despite many studies on CPPs, the mechanisms by which CPPs enter the cells have not been completely understood.
For a long time, it was believed that CPPs would most likely enter cells by a passive process, which is temperature and receptor independent [46] . Endocytosis, being the most common process used by cells to absorb materials from their environment, can also be used as the translocation pathway of CPPs into cells [46, 47] . Endocytosis is a generic term for several different processes, such as phagocytosis for large particles and pinocytosis for smaller ones, as well as receptor-mediated endocytosis in which clathrin or caveolin pits are involved [24, 43, 46] . Several receptors were uncovered to be involved in internalization of CPPs, such as chemokine receptors, syndecans [48, 49] , neuropilins [50, 51] , the family of integrins [52] , homing sequences, and positively-charged scavenger receptors [53, 54] . Micropinocytosis appears to be another pathway for some of CPPs. that is mediated by positively charged residues interacting with phosphoinositides. A nonendocytotic, receptor-free, energyindependent cellular process is another mechanism of the CPP translocation across biologic membranes, including formation of inverted micelles, direct translocation through the lipid bilayer, and pore formation on the membrane [46, 47, 55, 56] . CPPs with high content in cationic residues are first absorbed at the cell surface to the numerous anionic moieties, such as sialic or phospholipidic acid or heparan sulfate proteoglycans [46, 57] . Which of these mechanisms a CPP will use is dependent on such parameters as concentration, size (with cargo), temperature, cell type, and modifications of CPPs or their cargo [43, 46, 55] .
The cell membrane is a heterogeneous double layer where some regions are denser and some others have more fluidity due to the presence of different lipid compositions. These properties in turn along with CPPs' properties can result in a variety of signaling pathways and different levels and modes of uptake which depend upon the conditions used for testing CPPs [58, 59, 60, 61, 62] . Since the synthesized amphipathic peptides commonly have positive charge and cancer cell membranes typically carry a net negative charge [63] , the elevated expression of anionic molecules such as proteoglycans [64] and the electrostatic attraction between them is believed to play a conclusive role in the cellular uptake of this peptides. Different studies indicated that endocytosis and direct translocation through the cellular membrane are the major mechanisms used by CPPs to gain entry into the cell [30] .
To determine if the synthesized peptides and nanoparticles can be utilized for the delivery of biologically relevant doses of EPR to cells, EPR was conjugated to these synthesized peptides using succinyl hydrolysable spacer which allows the drug to release after the uptake into the cells [65] . The antitumor activity of free drug (EPR) was then examined and compared to Furthermore, K3W4K3-E8 showed the lowest cytotoxicity of among all products produced in the present study. Generally, CPPs and CPPs-E4 or -E8 nanoparticles displayed improved anti-proliferative activity compared to free EPR (at higher concentrations). This enhanced antitumor activity could be attributed to the high cellular uptake tendency of the synthesized peptides or nanoparticles [66] . Nanoparticles showed greater intracellular uptake and less cytotoxicity. Moreover, the effect of EPR was better for nanoparticles compared to CPPs at higher concentration levels. The reason for this may be due to the changes in conformation and the charge of peptides of nanoparticles and diverse uptake pathways following an interaction with cell membrane.
It was reported that the endocytosis pathway may be responsible for the vast majority of cationic peptide internalization at low concentrations. It was shown that at low concentration, endocytosis of peptides could occur which may result in endosomal entrapped peptides and possible metabolic degradation [67, 68] . However numerous evidences suggest that direct penetration does occur at high concentrations (above 10 µm) [67, 68] . Pathways of the uptake depended concentration can explain variation of cytotoxicity and uptake of peptides. As shown, the uptake of peptides and following antitumor activity of EPR-CPPs and EPR-CPPs-E8 increased at high concentrations and this can possibly due to direct translocation at high concentration.
Conclusion
In summary, different linear peptides were successfully synthesized separately or conjugated to EPR. Poly glutamate (E4 or E8) was also conjugated to the peptides and peptides-EPR to prepare nanoparticles. The effect of various CPPs and their nanoparticles was then evaluated against a breast cancer cell line (MCF-7). Results showed that cytotoxicity was concentration and time dependent. Binding of poly glutamate to CPPs resulted in a significant decrease in cytotoxicity. Interestingly, CPPs-E8 nanoparticles showed lower cytotoxicity than CPPs-E4.
Uptake was concentration dependent for all of the CPPs and nanoparticles up to 25 µM.
Among all of the CPPs, W2K4W2 exhibited the lowest uptake. K3W4K3-E8, K2W4K2-E8
and W3K4W3-E8 reached the highest uptake at the concentration of 50 µM and there was no significant difference between each of them and their nanoparticles. Following the conjugation of EPR to the CPPs and nanoparticles, the anti-proliferative activity of EPR increased significantly at the highest concentration (25 µM). CPPs-EPR-nanoparticles displayed higher anti-proliferative activity compared to CPPs-EPR conjugates especially at 25 µM. Interestingly, CPPs-E8-EPR nanoparticles showed higher anti-proliferative activity than CPPs-E4-EPR. K3W4K3-E8-EPR nanoparticles exhibited the lowest cytotoxicity, high cellular uptake and the highest anti-proliferative activity at 25 µM following 48h incubation.
Taking together the aforementioned advantages, the peptide nanoparticles are proposed as more potential nanosystems for cellular delivery of drugs at high concentration levels compared to CPPs, but they should also be tested in-vivo.
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